UK markets closed
NIKKEI 225
38,073.98 -128.39 (-0.34%) HANG SENG
18,537.81 +223.95 (+1.22%) CRUDE OIL
79.06 +0.07 (+0.09%) GOLD FUTURES
2,340.00 +17.70 (+0.76%) DOW
39,307.88 +251.49 (+0.64%) Bitcoin GBP
49,640.14 -314.51 (-0.63%)
BIO May 2024 360.000 call
OPR - OPR Delayed price. Currency in USD
Add to watchlist
As of 09:54AM EDT. Market open.
| Previous close | 3.5300 |
| Open | 2.2800 |
| Bid | 0.0000 |
| Ask | 2.2500 |
| Strike | 360.00 |
| Expiry date | 2024-05-17 |
| Day's range | 2.2800 - 2.2800 |
| Contract range | N/A |
| Volume | |
| Open interest | 4 |
ZacksBio-Rad (BIO) Q1 Earnings Surpass Estimates, Margins Down
Bio-Rad's (BIO) Clinical Diagnostics arm registers growth in Q1, primarily driven by an increased demand for quality control, blood typing, and diabetes products.
Insider MonkeyBio-Rad Laboratories, Inc. (NYSE:BIO) Q1 2024 Earnings Call Transcript
Bio-Rad Laboratories, Inc. (NYSE:BIO) Q1 2024 Earnings Call Transcript May 7, 2024 Bio-Rad Laboratories, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good afternoon everyone, and welcome to today’s Bio-Rad First Quarter 2024 Earnings Results Conference Call. At this […]
- Thomson Reuters StreetEvents
Q1 2024 Bio Rad Laboratories Inc Earnings Call
Q1 2024 Bio Rad Laboratories Inc Earnings Call
© 2024 Yahoo. All rights reserved.